Insurers Retain Optimism On Backstop Bill
By Steven Brostoff, Washington Editor
NU Online News Service, Oct. 14, 9:59 a.m. EST, Washington?The insurance industry remained hopeful today that Congress would get together to approve a terrorism insurance bill despite a seeming impasse over tort reform and a tight schedule.
Gary Karr, a representative of the Washington-based American Insurance Association, noted that a similar scenario played out during the Senate's consideration of its version of terrorism insurance legislation, S. 2600.
At that time, Mr. Karr noted, there was a dispute over tort reform and many observers believed the legislation was dead. However, the Senate eventually did pass a bill, he said.
The dispute over tort reform involves the extent to which American businesses that are hit by a terrorist attack should be liable for punitive damages in lawsuits filed against them by victims.
One of the Republican leaders on terrorism insurance, House Financial Services Committee Chairman Mike Oxley, R-Ohio, accused Senate Democrats of being more interested in "trial lawyer protection than taxpayer protection."
Congress is not in session today because of the Columbus Day holiday. The Senate will convene tomorrow, and the House on Wednesday, in what will be the last week before breaking for the Nov. 5 election.
Congress may reconvene after the election for a "lame duck" session.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
